GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yantai Dongcheng Biochemicals Co Ltd (SZSE:002675) » Definitions » Accumulated Depreciation

Yantai Dongcheng Biochemicals Co (SZSE:002675) Accumulated Depreciation : ¥0 Mil (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is Yantai Dongcheng Biochemicals Co Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Yantai Dongcheng Biochemicals Co's quarterly accumulated depreciation increased from Sep. 2024 (¥0 Mil) to Dec. 2024 (¥-956 Mil) but then stayed the same from Dec. 2024 (¥-956 Mil) to Mar. 2025 (¥0 Mil).

Yantai Dongcheng Biochemicals Co's annual accumulated depreciation increased from Dec. 2022 (¥-675 Mil) to Dec. 2023 (¥-792 Mil) and increased from Dec. 2023 (¥-792 Mil) to Dec. 2024 (¥-956 Mil).


Yantai Dongcheng Biochemicals Co Accumulated Depreciation Historical Data

The historical data trend for Yantai Dongcheng Biochemicals Co's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yantai Dongcheng Biochemicals Co Accumulated Depreciation Chart

Yantai Dongcheng Biochemicals Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -492.09 -570.41 -675.11 -792.35 -956.09

Yantai Dongcheng Biochemicals Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -859.31 - -956.09 -

Yantai Dongcheng Biochemicals Co Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.


Yantai Dongcheng Biochemicals Co Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Yantai Dongcheng Biochemicals Co's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.


Yantai Dongcheng Biochemicals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 7 ChangBaishan Road, Yan Tai Development Zone, ShanDong, CHN, 264006
Yantai Dongcheng Biochemicals Co Ltd is a biochemical analytical profile index (API) manufacturers in China. In addition, the company also focuses on the development of finished preparation which covers the therapeutic area of cardiovascular, oncology, orthopedics, and anti-infection. Its product offering includes heparin sodium, chondroitin sulfate, marine collagen, hyaluronic acid, glucosamine, heparinoids, and cytochrome C. The company's API products have been exported to more than fifty countries and regions, including the United States of America, Germany, Austria, and Japan.
Executives
Xin Hong Bo Directors, executives
Luo Zhi Gang Executives
You Shou Yi Directors, executives
Lv Chun Xiang Supervisors
Sun Hong Tao Supervisors
Yi Qiong Executives
Yang Zhen Qiu Executives
Bai Xing Hua Directors, executives
Song Zhao Long Supervisors
Wen Lei Director
Zhu Chun Ping Executives
Qi Dong Qi Directors, executives
Liu Xiao Jie Securities Affairs Representative
Wang En Zheng Independent director
Shi Tao Supervisors

Yantai Dongcheng Biochemicals Co Headlines

No Headlines